Risk for PSE was lower for patients treated with ARBs and higher for those receiving calcium channel blockers, beta-blockers
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy PolicyOk